Авторы

  • Хужамбердиев М.А., Узбекова Н.Р., Юлдашева С.Л.

Ключевые слова:

ишемическая болезнь сердца, фруктозы-1,6-дифосфата, антиаритмический, антиангинальный и антиишемический эффект.

Библиографические ссылки

1. Alva N., Alva R., Carbonell T. Fructose 1,6-Bisphosphate: A Summary of Its Cytoprotective Mechanism Current Medicinal Chemistry. 2016;23 (39). DOI: 10.2174/0929867323666161014144250

2. Badalian G.O., Episkoposian N.G., Amatuni G.V. Effect of fructose-1,6-diphosphate and Trental on the erythrocyte aggregating capacity in ischemic heart disease Terapevticheskii Arkhiv. 1987;59(7): 92–95. PMID: 3672368.

3. Cargnoni A., Condorelli E., Boraso A., et al. Role of timing of administration in the cardioprotective effect of fructose-1,6-bisphosphate Cardiovascular Drugs and Therapy. 1992;6(3):209–217. DOI: 10.1007/BF00051141.

4. Chen J., et al. Hemodynamics and metabolic effects of fructose 1–6 diphosphate in ischemia and shock — experimental and clinical observations Annals of Emergency Medicine. 1986;15(12):147 0–1477. DOI: 10.1016/S0196-0644(86)80946-5.

5. Lazzarino G., Tavazzi B., Di Pierro D., Giardina B. Ischemia and reperfusion: effect of fructose-1,6-bisphosphateFree Radical Research Communications. 1992;16(5):325–339. DOI: 10.3109/10 715769209049185.

6. Xu H., Wang M., Zhao T., Yu X., Wang F. Protective effects of fructose-1,6-bisphosphate postconditioning on myocardial ischaemia-reperfusion injury in patients undergoing valve replacement: a randomized, double-blind, placebo-controlled clinical trial European Journal of Cardio-Thoracic Surgery. 2024;66(2): ezae306. DOI: 10.1093/ejcts/ezae306. PMID: 39120890

7. Cherniy VI, Kurilenko YaV.Study of the effectiveness of fructose-1,6-diphosphate in the complex treatment of cardiac surgery patients who underwent coronary artery bypass grafting with cardiopulmonary bypass EmergencyMedicine.2022;18 (2). DOI: 10.22141/2224-0586.18.2.2022.1472